Rankings
▼
Calendar
VCEL Q4 2024 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$75M
+16.0% YoY
Gross Profit
$58M
77.6% margin
Operating Income
$18M
24.5% margin
Net Income
$20M
26.3% margin
EPS (Diluted)
$0.38
QoQ Revenue Growth
+30.2%
Cash Flow
Operating Cash Flow
$22M
Free Cash Flow
$8M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$433M
Total Liabilities
$141M
Stockholders' Equity
$292M
Cash & Equivalents
$75M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$75M
$65M
+16.0%
Gross Profit
$58M
$49M
+20.6%
Operating Income
$18M
$13M
+45.1%
Net Income
$20M
$13M
+52.4%
Revenue Segments
MACI Implants And Kits
$68M
100%
← FY 2024
All Quarters
Q1 2025 →